6 Important HIV Research Findings From CROI 2015
March 23, 2015
Every year, the two good doctors Josep M. Llibre, M.D., and Benjamin Young, M.D., Ph.D., get together over a meal to discuss their takes on some of the important messages that emerge from an international HIV conference. This year, they met at CROI 2015, in Seattle, Washington, to compare what they thought were the top findings presented at the conference. Here are the take-home messages they felt came from CROI 2015.
Table of Contents
Josep M. Llibre, M.D., is in the HIV Unit of the "Lluita contra la SIDA" Foundation at University Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. Llibre has received funding for research or payment for conferences or participation on advisory boards from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen-Cilag, Merck Sharp & Dohme, and ViiV Healthcare.
Benjamin Young, M.D., Ph.D., is senior vice president and chief medical officer of the International Association of Providers of AIDS Care based in Washington, D.C., and an adjunct professor at the Josef Korbel School of International Studies at the University of Denver. Young has received consulting or speaking fees from Bristol-Myers Squibb, Gilead Sciences, Merck & Co., and ViiV Healthcare. He has received research funding from Bristol-Myers Squibb Company, Gilead Sciences, Merck & Co., and ViiV Healthcare.
This article was provided by TheBodyPRO.com. It is a part of the publication The 22nd Conference on Retroviruses and Opportunistic Infections (CROI 2015).
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.